Form4insider filings, from the source

Company · CIK 0001661059 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

NextCure, Inc. · NXTC

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $1.7M · 2sales $185k · 1net $1.5M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJul 26Jul 28Jul 31Aug 3Aug 5Aug 8Aug 11

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 10, 2026 SForm 4 →Aug 12, 11:35 am EDTSimcere Zaiming, Inc. +5Other30,000$6.16$184,800308,636−8.86%
Jul 30, 2026 PForm 4 →Aug 3, 5:53 pm EDTADAR1 Capital Management, LLC +110% Owner329,153$4.93$1,624,120722,419+83.7%
Jul 27, 2026 PForm 4 →Jul 29, 6:18 pm EDTADAR1 Capital Management, LLC +110% Owner17,608$4.98$87,713393,266+4.69%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 18, 2026 AForm 4 →Jun 22, 4:15 pm EDTEllen FeigalDirector2,340——2,340—
Jun 18, 2026 AForm 4 →Jun 22, 4:15 pm EDTElaine V JonesDirector2,340——2,340—
Jun 18, 2026 AForm 4 →Jun 22, 4:14 pm EDTAnne Elizabeth BorgmanDirector2,340——2,340—
Jun 18, 2026 AForm 4 →Jun 22, 4:14 pm EDTStephen W WebsterDirector2,340——2,340—
Jun 18, 2026 AForm 4 →Jun 22, 4:14 pm EDTDavid S KabakoffDirector3,510——3,510—
Jun 18, 2026 AForm 4 →Jun 22, 4:14 pm EDTJohn G HoustonDirector2,340——2,340—